You searched for Humanized antibody - Page 26 of 44

News and Trends 12 Oct 2022

Novavax COVID-19 vaccine data supports homologous and heterologous boosting

…a type of antibody) levels increased significantly relative to pre-boost levels, rising above the level correlated with 95% vaccine efficacy in a recent USG study. Neutralizing antibodies against the prototype…

October 12, 2022 - 3 minutesmins - By Liza Laws

Patrick Baeuerle Successful German Biotech Leader

Interview 17 Apr 2017

Meet One of the Most Successful German Biotech Leaders Ever

…looked like a disaster in the first place, created the opportunity to develop a bispecific T cell-engaging antibody that was in-licensed from inventors at Munich’s LMU. This antibody ultimately became…

April 17, 2017 - 6 minutesmins - By Philip Hemme

In Depth 15 Aug 2025

How biotech is improving the life of your cat

…from human or canine drugs isn’t a durable option. If you give a cat a human or dog-like antibody, the cat’s immune system may attack it. So, companies build the…

August 15, 2025 - 9 minutesmins - By Jules Adam

In Depth 16 Jul 2025

Eight rare autoimmune diseases biotechs are fighting to treat

…two candidates for Graves’ disease: batoclimab and IMVT-1402. In September 2024, the company reported positive phase 2a results from a clinical trial investigating the monoclonal antibody batoclimab in patients with…

July 16, 2025 - 12 minutesmins - By Willow Shah-Neville

probiodrug alzheimers disease mechanism of action

News and Trends 30 Aug 2017

German Scientists Publish New Mechanism of Action Against Alzheimer’s

…developing a therapeutic antibody with a unique mode of action against Alzheimer’s, PBD-C06. The company announced yesterday the publication in the Journal of Biological Chemistry of the detailed binding mechanism…

August 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Oct 2022

Merck contributing to Jacobio Pharma colorectal cancer clinical trial

…treatment; combination therapy with SHP2 inhibitor, PD-1 monoclonal antibody and cetuximab. About Erbitux (cetuximab) Erbitux is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal…

October 13, 2022 - 2 minutesmins - By Jim Cornall

researchers in lab; biotech collaboration

News and Trends 14 Jul 2022

GenScript ProBio enters strategic partnerships with two South Korean biotechs

…DAAN Bio Therapeutics Based in Seoul, South Korea, DAAN Bio Therapeutics has developed an integrated immune-oncology drug research platform for the discovery of novel antibody and cell therapy drugs for…

July 14, 2022 - 3 minutesmins - By Omnia Ibrahim

News and Trends 30 Sep 2024

The race for a bird flu vaccine: milestones and breakthroughs

…of an antigen molecule to which an antibody attaches itself – the immune system relies on memory of the earlier infection. “There are some bits between H5 and H1 which…

September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 2 Jul 2025

Top biotech deals in June 2025

…was slashed earlier this year. Meanwhile, this is XOMA Royalty’s second purchase in a month after it snagged the monoclonal antibody mezagitamab from the Swedish company BioInvent for $20 million. …

July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 20 Jul 2022

BigHat Biosciences raises $75M to design safer, more effective antibodies

A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series…

July 20, 2022 - 4 minutesmins - By Liza Laws

boehringer ingelheim cancer vaccine amal therapeutics

News and Trends 10 Apr 2020

Coronavirus Pandemic Bites into European Cancer Research

…which specializes in cancer immunotherapy, has temporarily halted patient recruitment into phase I clinical trials for two of its cancer drug candidates, a bispecific antibody and a monoclonal antibody. On…

April 10, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 9 Jul 2018

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

BioArctic, based in Stockholm, has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial tested the antibody…

July 9, 2018 - 3 minutesmins - By Alexander Burik

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Novavax COVID-19 vaccine data supports homologous and heterologous boosting

Meet One of the Most Successful German Biotech Leaders Ever

How biotech is improving the life of your cat

Eight rare autoimmune diseases biotechs are fighting to treat

German Scientists Publish New Mechanism of Action Against Alzheimer’s

Merck contributing to Jacobio Pharma colorectal cancer clinical trial

GenScript ProBio enters strategic partnerships with two South Korean biotechs

The race for a bird flu vaccine: milestones and breakthroughs

Top biotech deals in June 2025

BigHat Biosciences raises $75M to design safer, more effective antibodies

Coronavirus Pandemic Bites into European Cancer Research

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!